Further, MAGE-C2 has been shown to regulate cancer cell proliferation through p53 ubiquitination whereby the E3 ubiquitin ligases TRIM28 and MDM2 compete for binding with MAGE-C2, releasing and activating MDM2 which subsequently ubiquitinates p53.170. Here, MAGEC2 is linked to cancer.